chevron_leftBack
As of 6 June 2026, Wakamoto Pharmaceutical Co.,Ltd. has a market cap of $75.88M USD, ranking #27545 globally and #2471 in Japan.
It ranks #2486 in the Healthcare sector, and #891 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$75.88MUSD
12.14B JPY
Revenue (TTM)
$58.94MUSD
9.43B JPY
EBITDA (TTM)
$3.17MUSD
508.0M JPY
Net Income (TTM)
-$1.39MUSD
-222.0M JPY
EBITDA Margin
5.4%
Profit Margin
-2.4%
PS Ratio
1.3
PB Ratio
1.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Tomoyuki Hirai
open_in_new
Employees
403
Founded
1929
Website
wakamoto-pharm.co.jp
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.9% | -0.9% | -2.8% | 13% | 23% | 7.7% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
4512
わかもと製薬株式会社
ISIN: JP3991200001
Shares Out.:
Shares Outstanding:
34.706M1
Shares Float:
15.343M2
|
349 JPY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Wakamoto Pharmaceutical Co.,Ltd.
Wakamoto Pharmaceutical Co.,Ltd. engaged in the manufacture and sale of pharmaceuticals, medical devices, and health food in Japan. The company offers Strong and Granule Wakamoto, gastrointestinal drugs for digestion, intestinal regulation, and nutritional supplementation, as well as Wakamoto Intestinal Remedy drug. It also provides AVANTBISE oral tablets, a supplement of bacteria to restore the balance of oral flora; and medicated toothpaste. The company was formerly known as Society for Nutrition and Raising Children Co., Ltd. and changed its name to Wakamoto Pharmaceutical Co.,Ltd. in July 1943. Wakamoto Pharmaceutical Co.,Ltd. was founded in 1929 and is headquartered in Tokyo, Japan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TSE: 4519
|
$81.66B
108K%
13.07T JPY
|
28.9
|
|
TSE: 4502
|
$52.21B
69K%
8.36T JPY
|
75.1
|
|
TSE: 4578
|
$36.84B
48K%
5.9T JPY
|
15.7
|
|
TSE: 4568
|
$30.37B
40K%
4.86T JPY
|
16.2
|
|
TSE: 4503
|
$25.82B
34K%
4.13T JPY
|
14.2
|
|
TSE: 4507
|
$16.91B
22K%
2.71T JPY
|
13.9
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
1M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
721K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
475K%
|
97.4
|
|
SIX: RO
|
$324.68B
428K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.43B
381K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$277.35B
365K%
218.9B CHF
|
20.5
|
chevron_leftBack